R&D Systems Hematology Controls and Calibrators has
completed the Class B Certification under the new European Union In
Vitro Diagnostic Regulation
This press release updates the IVDR Classification to Class B
from the prior Class C.
MINNEAPOLIS, Nov. 11,
2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:
TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR)
certification for its R&D Systems Hematology Controls and
Calibrators. This certification confirms that the products comply
with the regulations and guidelines set forth by the European Union
for in-vitro diagnostic devices.
This IVDR certification demonstrates the product's exceptional
quality standards, ensuring high levels of accuracy, precision, and
reliability. It marks an important milestone in Bio-Techne's
commitment to meeting the needs of healthcare professionals.
Hematology Controls and Calibrators are essential components in
the laboratory setting that support accuracy in patient testing.
With the IVDR certification, customers can be assured that
Bio-Techne's R&D Systems Hematology Controls and Calibrators
meet the rigorous standards required in hematology.
"At Bio-Techne, we take pride in designing and manufacturing
products that enable researchers and healthcare professionals to
improve patients' lives. We are thrilled to be able to offer IVDR
certified Hematology Controls and Calibrators to our customers,
ensuring they receive the highest quality products," said Dr.
Matt McManus, President of
Bio-Techne's Diagnostics & Spatial Biology Segment.
About Bio-Techne Corporation
Bio-Techne
Corporation (NASDAQ: TECH) is a global life sciences company
providing
innovative tools and bioactive reagents
for the research
and clinical diagnostic communities. Bio-Techne, in
partnership with Wilson Wolf, is
creating products such as media and cytokines that are specifically
tailored to G-Rex® Bioreactors, including right-sized reagent
quantities in containers that are tailored to high throughput
closed-system manufacturing.
For more information on Bio-Techne and its brands,
please visit https://www.bio- techne.com or follow
the Company on social
media at: Facebook, LinkedIn, Twitter or YouTube.
Contact: David
Clair, Vice President, Investor Relations &
Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download
multimedia:https://www.prnewswire.com/news-releases/updated-bio-techne-announces-ivdr-certified-hematology-controls-and-calibrators-302301804.html
SOURCE Bio-Techne Corporation
